Linked Life Data

9636549

Source:http://linkedlifedata.com/resource/pubmed/id/9636549

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-7-8
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1351-2
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9636549-Adolescent, pubmed-meshheading:9636549-Adult, pubmed-meshheading:9636549-Aged, pubmed-meshheading:9636549-Antigens, CD3, pubmed-meshheading:9636549-Antilymphocyte Serum, pubmed-meshheading:9636549-Child, pubmed-meshheading:9636549-Communicable Diseases, pubmed-meshheading:9636549-Cyclosporine, pubmed-meshheading:9636549-Drug Therapy, Combination, pubmed-meshheading:9636549-Female, pubmed-meshheading:9636549-Graft Rejection, pubmed-meshheading:9636549-Graft Survival, pubmed-meshheading:9636549-Humans, pubmed-meshheading:9636549-Immunosuppressive Agents, pubmed-meshheading:9636549-Kidney Transplantation, pubmed-meshheading:9636549-Male, pubmed-meshheading:9636549-Middle Aged, pubmed-meshheading:9636549-Muromonab-CD3, pubmed-meshheading:9636549-Mycophenolic Acid, pubmed-meshheading:9636549-Postoperative Complications, pubmed-meshheading:9636549-Prospective Studies, pubmed-meshheading:9636549-Survival Rate, pubmed-meshheading:9636549-T-Lymphocyte Subsets, pubmed-meshheading:9636549-Tacrolimus
pubmed:year
1998
pubmed:articleTitle
ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.
pubmed:affiliation
Division of Transplantation, Allegheny Hahnemann University Hospitals, Philadelphia, Pennsylvania 19102, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't